Lv72
3720 积分 2023-06-23 加入
[Chinese guideline for the diagnosis, treatment and management of lupus nephritis (2025)]
3天前
已完结
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
8天前
已完结
The race to reset autoimmune diseases
1个月前
已完结
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A report from the CIBMTR
1个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
1个月前
已完结
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
1个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
皖公网安备34019202002308
